South Korean police tried to search Cheongwadae's office again.South Korea's ruling party has made it a unified position within the party to oppose the "special inspection law for civil strife" and "Jin Jianchit's inspection law". South Korea's ruling National Power Party said that it will make it a unified position within the party to oppose the "special inspection law for civil strife" and "Jin Jianchit's inspection law". (CCTV News)This year, the amount of M&A transactions involving listed companies in Hong Kong has reached 38 billion US dollars, which has triggered a rare bidding war. This year is expected to be the busiest year for M&A transactions involving listed companies in Hong Kong in the past decade, with industries ranging from skin care products to logistics real estate, and the bidding war has also warmed up. It is reported that China Mobile's bid for Hongkong Broadband may face competition from American private equity firm I Squared Capital. Bi Hua, chairman of Fenmei Packaging, is negotiating with Qihao Capital to jointly counter the privatization offer of Shandong Xinjufeng. The data shows that the scale of M&A transactions for listed companies in Hong Kong has reached $38 billion this year, the highest level since 2017, including the merger of Guotai Junan Securities and Haitong Securities, a smaller competitor, to become the largest brokerage firm in China.
Sources: The Bank of Japan tends to keep interest rates unchanged next week. Five sources familiar with the Bank of Japan's thinking said that the Bank of Japan tends to keep interest rates unchanged next week because policymakers tend to spend more time examining overseas risks and clues about salary increase next year. Any similar decision will increase the possibility that the Bank of Japan will raise interest rates at its meeting in January or March next year, when there will be more information about the wage increase next year. The source also said that there was no consensus within the Bank of Japan on the final decision, and some people in the Committee still believed that Japan had met the conditions for raising interest rates in December. This decision will depend on each member's belief in the possibility of achieving wage-driven sustained price increases in Japan. If upcoming events, such as next week's meeting of the Federal Reserve, trigger another sharp fall in the yen, thus intensifying inflationary pressure, the Bank of Japan may also agree to raise interest rates. But overall, many BoJ policymakers seem to be in no hurry to pull the trigger.South Korea's ruling party has made it a unified position within the party to oppose the "special inspection law for civil strife" and "Jin Jianchit's inspection law". South Korea's ruling National Power Party said that it will make it a unified position within the party to oppose the "special inspection law for civil strife" and "Jin Jianchit's inspection law". (CCTV News)SAIC: Haitong Taicang Automobile Terminal has been put into production and operation. According to the official WeChat official account news of SAIC, today, Haitong Taicang Automobile Terminal jointly built by SAIC, Shanghai Port Group and Jiangsu Port Group has been put into production and operation, with an annual throughput of 1.3 million vehicles.
Pakistan KSE-100 index rose 1% to 112,128.50.Renhe Pharmaceutical invested in Jiangxi to establish a health industry company. According to the enterprise search APP, Jiangxi Renhe Jiuniuai Health Industry Co., Ltd. was recently established, with Xin Li as the legal representative and a registered capital of 1 million yuan. Its business scope includes: food Internet sales, health food production, health care services (non-medical), health consulting services, sales of first-class medical devices, sales of agricultural and sideline products, etc. Enterprise survey shows that the company is jointly held by Renhe Pharmaceutical and Xin Li.The tenth batch of centralized procurement of drugs organized by the state will be opened in Shanghai today (12th), and the bid will be selected. It is understood that this collection involves a total of 62 drugs and 263 product specifications, which is the highest in all previous collections. Covers a variety of therapeutic fields such as hypertension, diabetes, tumor, cardiovascular and cerebrovascular diseases, infection, mental illness, and electrolyte supplementation. (CCTV Finance)
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14